| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_558683482767474d021cb00b2b0b66c2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-16021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-701
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-686
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-686
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
| filingDate |
2017-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b273de7aa9c411c2002f6c1d6820e36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee578ea9fb20e88c601914192a42d695
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad09b291c39c49a34be313b334b1a88e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0408698b92c9623c64c71c329ef5567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a44a597df069475c3f0ba083d1b8cd6 |
| publicationDate |
2019-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-110073005-A |
| titleOfInvention |
How to detect norovirus |
| abstract |
The present disclosure provides methods and compositions for determining whether a patient exhibiting acute gastroenteritis would benefit from treatment with a therapeutic agent that inhibits Norovirus genogroup I (GI) or norovirus genogroup II (GII). The methods disclosed herein are based on the detection of norovirus genogroup I (GI) and norovirus genogroup II (GII) in stool samples without extraction of viral nucleic acids from clinical samples prior to performing real-time reverse transcription PCR. The present disclosure also provides kits for practicing the methods. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114317814-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110791589-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111187861-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111187861-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112725543-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112725543-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111019908-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110592284-A |
| priorityDate |
2016-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |